Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDAs approval process. The FDA claims the companies are mass marketing their GLP-1s as similar alternatives to FDA-approved drugs
Building on Aons initial analysis conducted in May 2025, the second phase of research expanded the study to include a larger, nationally representative sample of 192,000 GLP-1 users
check with Novo Nordisks savings program
GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects
One possible way to minimize the side-effects of the single drugs is to combine them to achieve synergistic effects, as reported recently with a combination of a DPP-IV inhibition, SSTR5 antagonism and GPR40 and TGR5 agonism, capable to raise circulatory active GLP-1(7-36) NH2 levels to more than 300-400 pM in mice (240)
Book An Appointment What should I expect during my first visit